The committee voted that FDA should restrict use of LYNPARZA plus abi/pred to these BRCAm mCRPC patients
It will help in bringing a significant benefit in compliance of ARV medication in the paediatric HIV treatment
Lebrikizumab is an investigational high-affinity and potent IL-13 inhibitor being studied in adult and adolescent patients
The strategic appointment is also critical to reinforcing Healthium’s market leadership, corporate governance and deep domain expertis
Once approved, Columvi will be the first CD20xCD3 T-cell-engaging bispecific antibody available to treat people in Europe with this aggressive lymphoma
Clinic will offer Comprehensive Genetic Counselling and Testing Services to empower patients with personalized care
The partnership will capitalize on the combined capabilities of the two organizations
The policymakers, doctors and, patient bodies discuss ways to implement thalassemia control programme nationally
This approval reflects Biocon Biologics' compliance with the highest international regulatory standards
The news on a shift in its focus comes after the refinement of Bayer’s early innovation framework
Subscribe To Our Newsletter & Stay Updated
